Literature DB >> 9197357

Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group.

O H Koning1, R J Ploeg, J H van Bockel, M Groenewegen, F J van der Woude, G G Persijn, J Hermans.   

Abstract

BACKGROUND: Delayed graft function (DGF) remains an important complication in renal transplantation. In this multicenter study, we investigated the influence of donor and recipient factors on the occurrence of DGF and DGF's effect on long-term graft survival.
METHODS: A total of 547 transplanted kidney allografts, retrieved from multi-organ donors, were analyzed, and results were compared with literature on kidney-only donors.
RESULTS: Median follow-up of patients without graft failure was 3.4 years. Twenty-four percent of the recipients developed DGF. In univariate analysis, the following factors significantly increased the incidence of DGF: (a) among the donor factors, mean creatinine level >120 micromol/L and prolonged cold ischemia time (CIT); and (b) among the recipient factors, previous transplant(s), no intraoperative use of mannitol, poor quality of reperfusion, absence of intraoperative diuresis, and pretransplant anuria or oliguria. After stepwise logistic regression, donor age, CIT, recipient's number of previous transplants, and intraoperative diuresis proved to be of independent prognostic value for the occurrence of DGF. Overall graft survival was 91%, 87%, and 72% at 3 months, 1 year, and 4 years after transplantation, respectively. In case of DGF, graft survival was approximately 10% lower when compared with cases with immediate graft function (P<0.001). No difference in incidence of DGF was found between grafts of multi-organ donors and kidney-only donors.
CONCLUSIONS: DGF results in an approximately 10% higher rate of graft failure. DGF incidence can be reduced by the administration of mannitol during transplantation, which minimizes CIT and optimizes donor management. Grafts from multi-organ donors and kidney-only donors appear to be of equal quality.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9197357     DOI: 10.1097/00007890-199706150-00015

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  25 in total

Review 1.  [The discovery of capillary Cd4 in kidney transplantation and the "renaissance" of humoral rejection].

Authors:  Helmut E Feucht
Journal:  Wien Klin Wochenschr       Date:  2006-07       Impact factor: 1.704

2.  Quantitative detection of promoter hypermethylation as a biomarker of acute kidney injury during transplantation.

Authors:  T K Mehta; M O Hoque; R Ugarte; M H Rahman; E Kraus; R Montgomery; K Melancon; D Sidransky; H Rabb
Journal:  Transplant Proc       Date:  2006-12       Impact factor: 1.066

3.  Predictive model for delayed graft function based on easily available pre-renal transplant variables.

Authors:  Gianluigi Zaza; Pietro Manuel Ferraro; Gianpaolo Tessari; Silvio Sandrini; Maria Piera Scolari; Irene Capelli; Enrico Minetti; Loreto Gesualdo; Giampiero Girolomoni; Giovanni Gambaro; Antonio Lupo; Luigino Boschiero
Journal:  Intern Emerg Med       Date:  2014-08-28       Impact factor: 3.397

Review 4.  Delayed graft function in the kidney transplant.

Authors:  A Siedlecki; W Irish; D C Brennan
Journal:  Am J Transplant       Date:  2011-09-19       Impact factor: 8.086

Review 5.  Critical care of the potential organ donor.

Authors:  Anna J Dare; Adam S Bartlett; John F Fraser
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

6.  Interleukin-9 release from human kidney grafts and its potential protective role in renal ischemia/reperfusion injury.

Authors:  Kirsten A Kortekaas; Dorottya K de Vries; Marlies E J Reinders; Ellen Lievers; Jan Ringers; Jan H N Lindeman; Alexander F M Schaapherder
Journal:  Inflamm Res       Date:  2012-09-13       Impact factor: 4.575

7.  Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation.

Authors:  Daqing Ma; Ta Lim; Jing Xu; Haidy Tang; Yanjie Wan; Hailin Zhao; Mahmuda Hossain; Patrick H Maxwell; Mervyn Maze
Journal:  J Am Soc Nephrol       Date:  2009-01-14       Impact factor: 10.121

8.  Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model.

Authors:  W M Bernhardt; U Gottmann; F Doyon; B Buchholz; V Campean; J Schödel; A Reisenbuechler; S Klaus; M Arend; L Flippin; C Willam; M S Wiesener; B Yard; C Warnecke; K-U Eckardt
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-23       Impact factor: 11.205

9.  "Nature versus nurture" study of deceased-donor pairs in kidney transplantation.

Authors:  Daniel W Louvar; Na Li; Jon Snyder; Yi Peng; Bertram L Kasiske; Ajay K Israni
Journal:  J Am Soc Nephrol       Date:  2009-04-23       Impact factor: 10.121

10.  Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/reperfusion damage, acute rejection, and chronic nephropathy.

Authors:  Julian R Pratt; Miriam E Jones; Jun Dong; Wuding Zhou; Paramit Chowdhury; Richard A G Smith; Steven H Sacks
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.